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Abstract Introduction Sickness absence is a major public
health problem. Research on sickness absence focuses on
interventions aimed at expediting return to work. However,
we need to know more about sustaining employees at work
after return to work. Therefore, this study investigated the
recurrence of sickness absence according to diagnosis.
Methods We analyzed the registered sickness absence data
of 137,172 employees working for the Dutch Post and
Telecom. Episodes of sickness absence were medically
certified, according to the ICD-10 classification of diseases,
by an occupational physician. The incidence density (ID)
and recurrence density (RD) of medically certified absen-
ces were calculated per 1,000 person-years in each ICD-10
category. Results Sickness absence due to musculoskeletal
disorders had the highest recurrence (RD = 118.7 per
1,000 person-years), followed by recurrence of sickness
absence due to mental disorders (RD = 80.4 per 1,000
person-years). The median time to recurrent sickness
absence due to musculoskeletal disorders was 409 days
after the index episode. Recurrences of sickness absence
due to musculoskeletal disorders accounted for 37% of the
total number of recurrent sickness absence days. For
recurrences of sickness absence due to mental disorders
this was 328 days and 21%, respectively. Unskilled
employees with a short duration (\5 years) of employment
had a higher risk of recurrent sickness absence. Conclu-
sions Interventions to expedite return to work of employees
sick-listed due to musculoskeletal or mental disorders
should also aim at reducing recurrence of sickness absence
in order to sustain employees at work.
Keywords Absenteeism  Sickness absence 
Epidemiology  Recurrence of sickness absence
Introduction
Sickness absence is a major problem, because of the loss of
economic productivity, the social insurance costs, and the
direct medical costs of long-term disability. In the past,
sickness absence was considered to be a socioeconomic
and political matter, rather than a medical or public health
problem [1, 2]. However, opinions changed after it was
reported that men and women with more than 15 days of
sickness absence per year are at increased risk of early
retirement on medical grounds and have a higher risk of
mortality [3–6]. Findings from the British Whitehall II
cohort and the French GAZEL cohort showed increased
mortality rates among employees who reported sick due to
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common disorders, such as mental disorders, respiratory
diseases and circulatory diseases [7, 8]. Therefore, sickness
absence is now considered to be a major public health
problem, and research on sickness absence has been given
priority in European countries [9, 10].
Most research on sickness absence has concentrated on
the transition of long-term diagnosis-specific sickness
absence towards disability pension [11–14]. In many Euro-
pean countries, long-term episodes of sickness absence
ultimately result in a disability pension [15]. Since 2004,
disability benefits in The Netherlands are granted after
2 years of sickness absence, regardless of the work-
relatedness of the impairments. Thus, a disability pension
encompasses both work-related injuries and non work-
related ill health retirement. Therefore, the societal costs of
work disability are high, and expediting return to work is an
important goal for interventions.
Although return to work is generally considered to be
directly related to recovery, the situation is usually more
complex, because varying levels of symptom severity are
loosely associated with patterns of sickness absence and
work disability. Return to work is conceptualized as a
dynamic process that not only involves an off-work phase
and a work re-entry phase, but also includes the mainte-
nance phase of sustainability of work performance. If
phase-specific goals are not achieved, then there is a risk of
a relapse to the off-work phase [16]. It should be noted that
this dynamic return to work concept is an expert opinion
that is not supported by scientific evidence. However, when
return to work is considered to be a dynamic process,
achieving full time work is not only an important outcome
of successful interventions, but also the maintenance of the
work status. This is especially important, because it is
likely that there is a risk of recurrent sickness absence after
return to work [17]. If this is so, then occupational health
monitoring should not end when full return to work is
achieved.
Considering the major impact of sickness absence on
society, employers, and employees, few studies have
reported on the recurrence of sickness absence. 48% of
employees with a long-term episode of sickness absence
(C6 consecutive weeks) at baseline had a recurrent long-
term episode during a 4-year follow-up, compared to 28%
of employees with no history of long-term sickness absence
at baseline [18]. Recurrences of sickness absence have
mainly been reported for employees with musculoskeletal
disorders, and especially low back pain [19]. In a cohort of
230 Canadian employees who were sick-listed due to low
back pain, 29 (12.6%) had a recurrence of sickness absence
due to low back pain within 6 months of return to work
[20]. In a population of American employees, Wasiak et al.
[21] reported a 17.2% rate of recurrent work disability due
to low back pain within 6 months. Within 12 months, 45%
of employees in The Netherlands experienced a recurrence
of sickness absence due to low back pain [22]. Troup et al.
[23] reported that 502 out of 802 employees, who had been
absent from work due to sciatic back pain, had a recurrence
of sickness absence within 24 months.
Using a Markov model to construct a hypothetical
cohort of employees, with a follow-up of 40 years, Burdorf
and Jansen estimated a total sickness absence burden due to
low back pain of approximately 140 weeks (6.6%) among
employees with a high physical load and approximately
30 weeks (1.4%) among employees with a low physical
load during a 40-year career [24]. However, the Markov
model assumes that all information about the future is
contained in the present state, meaning that future states are
independent of past states. In other words, the Markov
model assumes that the probability of transition between
health states is constant over time and independent of
earlier health states. There is evidence, however, that a
history of sickness absence predicts future episodes of
sickness absence [25]. Furthermore, it is likely that the risk
of sickness absence changes when employees return to
work [17].
Instead of using a mathematical Markov model for
cohort simulation, studying the incidence and recurrence of
sickness absence simultaneously may lead to a better
understanding of the natural pattern and distribution of
sickness absence in the working population. Therefore, the
present study investigated the incidence and recurrence of
sickness absence according to diagnosis over a 7-year
period. If we can identify categories in which sickness
absence is a recurrent problem, then preventive efforts can
target to those categories.
Methods
Dynamic Cohort Study
This study included employees who worked for the Dutch
Post and Telecom in the period from 2001 to 2007.
Approximately 70% of the employees worked for the
Dutch Post, mostly as post sorters (repetitive arm move-
ments and lifting post bags), postmen (walking long dis-
tances and carrying parcels), or post officers (sedentary
clerical work and customer services). The other 30% of the
employees worked for the Dutch Telecom in the installa-
tion and maintenance of telephone, telefax, and internet
systems or in call center and customer service activities.
The direct measurement of a cumulative incidence tra-
ditionally requires a study of a fixed cohort. Such cohorts
are suitable as long as the follow-up time and loss to fol-
low-up are limited. However, the turn-over within our
study population was high, especially because Dutch Post
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employees work on a temporary basis. This would imply a
high loss to follow-up if we chose an inception cohort.
Therefore, we preferred a dynamic cohort study design to
estimate the incidence density of diagnosis-specific sick-
ness absence. A dynamic cohort is defined as a population
that changes because some people enter and others leave
during the study period [26]. The advantage of a dynamic
cohort is that the population characteristics remain stable,
and do not change over time, whereas in an inception
cohort, for example, age increases with follow-up.
Employees contributed to the person years at risk as
long as they worked for the Dutch Post and Telecom, but
their data were right censored on the date on which they
left the company, implying that they did not further con-
tribute to the person years at risk, i.e. the denominator
of the incidence or recurrence density. Of the 67,316
employees who were included in the study on January 1,
2001, 51,280 resigned or were discharged during the study
period. 69,856 employees started working for the Post and
Telecom companies after January 1, 2001, and were
included on the date that they entered employment; 48,231
of them left their job again before the end of the study
period and were right censored on the date on which they
left the company.
Sickness Absence Policies
In The Netherlands, employees report sick to their employer,
who passes the sick report onto the occupational health
service on the first day of sickness absence. If an employee
returns to work within the first two weeks of absence, the
employer reports the date of return to work to the occupa-
tional health service, and the episode remains self-certified.
An employee who does not return to work must visit the
occupational physician (OP), usually in the third week of
absence, for medical certification of sickness absence
according to the 10th International Classification of Diseases
[27]. If an employee does not keep an appointment to visit the
OP because of full return to work, the sickness absence
episode is encoded and registered by an administrator on the
date of full return to work with equal earnings as before
sickness absence.
Exclusion Criteria
• Episodes of sickness absence lasting 1–3 weeks, which
were not medically certified;
• 2,880 episodes of sickness absence coded by adminis-
trators instead of certified by OPs;
• 2,501 episodes of sickness absence certified by OPs as
complaints not elsewhere classified (R00–R99, such as
fatigue, diffuse pain, and malaise); it is questionable
whether these are medical diagnoses and, if so, they are
likely to be unreliable;
• 653 episodes of sickness absence certified by OPs as
pregnancy and child birth (ICD-10 O00 to O99).
Employees who were absent for longer than 1 year were
right censored after 365 days of sickness absence, because a
disability pension was granted after 1 year of work disabil-
ity. Although Dutch disability pension policies changed on
January 1, 2004, the recurrence density of medically certified
sickness absences did not change abruptly (Fig. 1). The
gradual increase in recurrence density up to 2004 and the
gradual decrease, thereafter, are due to the time needed for an
index episode and a recurrent episode to occur, respectively.
Based on these results, we chose to continue to censor
employees after 1 year of sickness absence despite the policy
changes.
Incidence and Recurrence Density
The first medically certified episode of sickness absence
since January 1, 2001, or since the date of entering
employment, was regarded as the index episode in this
study. It should be acknowledged that this is not neces-
sarily the first episode of sickness absence exceeding 3
consecutive weeks, because people who were employed in
January, 2001, may have had earlier episodes of sickness
absence. The incidence density (ID) was calculated by
dividing incident episodes of sickness absence in each
ICD-10 category by the person-years at risk of the total
population, and was expressed per 1,000 person-years.
Episodes of certified sickness absence starting more
than 28 days after full return to work with equal earnings,
were regarded as recurrences. The recurrence density (RD)
of sickness absence was calculated by dividing the number
of recurrences in an ICD-10 category by the person-years
of employees who had a previous episode of sickness
absence within the same ICD-10 category. The time to
onset of the first recurrence of sickness absence after the
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Fig. 1 Trend in the recurrence density per 1,000 person-years during
the study period
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index episode and the median duration of recurrent episodes
of sickness absence, were calculated with Kaplan–Meier
survival analysis. We also counted the total number of days
of recurrent sickness absence episodes to assess the burden
of recurrent sickness absence per ICD-10 category.
Statistical Analysis of Recurrences
The following characteristics were retrieved from the
human resources registers of the companies: gender (male,
female), age (\35, 35–44, 45–54, C55 years), marital sta-
tus (married, unmarried), employment (full-time, i.e. C36 h
per week, or part-time, i.e. \36 h per week), the duration
of employment (0–4 years, 5–9 years, 10–14 years, 15–
19 years, C20 years), and salary scales (1–2, 3, 4–5, 6–7, C8
reflecting net monthly salaries on a full-time basis ranging
between EUR 1,200 and EUR 3,000). The salary scales
reflected the occupational level rather than the household
income. The socioeconomic status (SES) was determined
from the zip code of the employee’s home address. The zip
codes were linked to a status score based on tables of the
Netherlands Institute for Social Research, in which all zip
codes in the Netherlands are ranked on a scale from 1 to
4,000, with 1 indicating the richest neighbourhood and
4,000 the poorest neighbourhood. This proxy for SES is
commonly used by the Dutch authorities for socioeconomic
policy-making [28, 29]. We computed the quartiles of these
status scores, distinguishing between high, upper average,
lower average, and low SES.
Gender, age, salary scales, SES, marital status, and
employment were included as covariates in a Poisson
regression analysis for counts in SPSS version 15 for
Windows. The Poisson regression model is expressed as:
P y ¼ kjx1; x2; . . .xið Þ ¼ ellk=k! with k ¼ 0; 1; 2; 3. . .
in which the log of the mean l is assumed to be a linear
function of the independent variables:
logðlÞ ¼ intercept þ b1  x1 þ b2  x2 þ    þ bi  xi
Considering the huge study population, we chose a 1%
significance level (a = 0.01) and computed 99% confi-
dence intervals (CIs).
Results
A total of 137,172 employees contributed 363,461 person-
years to the study population and 36,342 employees had at
least one certified episode of sickness absence between
January, 2001 and December, 2007.
The highest IDs were found for sickness absence due to
musculoskeletal disorders and mental disorders (Table 1).
The RD of sickness absence due to musculoskeletal dis-
orders was 118.7 per 1,000 person-years, which is 1.5 times
higher than the RD in the total population (81.6 per 1,000
person-years). The RD of sickness absence due to mental
disorders was 80.4 per 1,000 person-years, which is of the
same magnitude as the RD in the total population.
The shortest median time to onset of a recurrent episode
of sickness absence was found in the category of infectious
diseases (Table 2). However, days of sickness absence
days due to recurrent infectious diseases accounted for only
1% of the total number of days of recurrent sickness
absence. The median time to onset of a recurrent sickness
absence due to musculoskeletal disorders was 409 days
after the index episode. Recurrences of sickness absence
due to musculoskeletal disorders accounted for 37% of the
total number of days of recurrent sickness absence. The
median time to onset of recurrent sickness absence due to
mental disorders was 328 days after the index episode, and
recurrent episodes of sickness absence due to mental dis-
orders accounted for 21% of the total number of days of
recurrent sickness absence.
Of the 12,129 employees with an episode of sickness
absence due to musculoskeletal disorders, 10,678 had
complete data, and in 1,451 cases (12%) data on one or
more independent variables were missing. 6,211 of the 7,197
employees with an episode of sickness absence due to mental
disorders had complete data, and in 986 cases (14%) data on
one or more independent variables were missing. Poisson
regression analysis only included employees with complete
data, and showed that employees of upper average and high
SES had a lower risk of recurrent episodes of sickness
absence due to musculoskeletal disorders compared to
employees of low SES (Table 3).
Employees in higher salary scales had a lower risk of
recurrent sickness absence due to musculoskeletal and
mental disorders than employees in salary scale 1–2 or 3.
Employees who worked for the company for C 5 years
also had a lower risk of recurrences due to musculoskeletal
and mental disorders compared to employees who worked
for the company for \5 years.
Discussion
This study presents data on the incidence and recurrence of
episodes of medically certified sickness exceeding three
consecutive weeks of absence from work. The ID and RD
of sickness absence due to musculoskeletal disorders were
the highest, followed by sickness absence due to mental
disorders. Our results showed that recurrences of sickness
absence due to musculoskeletal disorders or mental disor-
ders were, in particular, a societal and economic burden,
because they accounted for 58% of the total number of
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days of recurrent sickness absence. Recurrences of sickness
absence due to musculoskeletal disorders and mental dis-
orders were especially frequent in unskilled employees
with a short duration of employment.
Musculoskeletal complaints, and particularly low back
pain and neck/shoulder/arm pain, are a major health
problem in the Netherlands. Our results showed that mus-
culoskeletal disorders were the most common specific
cause of sickness absence, and the recurrence of muscu-
loskeletal disorders has been reported to range between 3
and 86% [30]. The lack of agreement on recurrence rates
has been attributed to differences in the definition of a
recurrence [31, 32] and the heterogeneity of populations in
which the rates were calculated. Our results showed that
50% of the recurrences of sickness absence due to mus-
culoskeletal disorders occurred within 409 days (i.e.
approximately 13 months) after the index episode. This is
in agreement with the findings of Van Duijn and Burdorf,
who reported that 45% of employees in The Netherlands
experienced a recurrent sickness absence due to low back
pain within 12 months. It should be noted that we studied
recurrent sickness absence, which may have resulted in an
Table 1 Incidence density (ID) and recurrence density (RD) of sickness absence (SA) per 1,000 employee-years according to ICD-10 category
Sickness absence diagnosis ICD-10 codes N ID (99% CI) N RD (99% CI)
Diseases of the musculoskeletal system M00–M99 12,129 46.3 (45.3–47.2) 4,023 118.7 (113.8–123.5)
Mental & behavioral disorders F00–F99 7,197 27.7 (27.0–28.4) 1,400 80.4 (74.9–86.0)
Diseases of the respiratory system J00–J99 4,568 23.3 (22.6–24.0) 788 74.6 (67.8–81.5)
Injury & poisoning S00–T98 4,555 19.6 (19.0–20.2) 480 41.9 (37.0–46.8)
Disease of the digestive system K00–K93 1,920 10.4 (10.0–10.8) 215 47.5 (39.2–55.9)
Diseases of the nervous system & sensory organs G00–H95 1,559 8.0 (7.6–8.4) 201 51.9 (42.4–61.3)
Diseases of the circulatory system I00–I99 1,356 6.9 (6.5–7.2) 182 52.9 (42.8–63.0)
Diseases of the genitourinary system N00–N99 991 5.2 (4.9–5.5) 95 38.8 (28.5–49.0)
Neoplasms C00–D48 618 2.8 (2.6–3.1) 53 42.0 (27.1–56.8)
Infectious & parasitic diseases A00–B99 566 2.5 (2.3–2.8) 13 9.6 (2.7–16.5)
Diseases of the skin & subcutaneous tissues D50–D89 501 2.7 (2.5–3.0) 45 35.5 (21.8–49.1)
Endocrine & metabolic diseases E00–E90 270 1.3 (1.2–1.5) 43 61.2 (37.1–85.3)
Disease of blood & blood forming organs L00–L99 112 0.6 (0.5–0.7) 4 14.2 (0.0–32.5)
Total 36,342 101.6 (100.2–102.9) 7,542 81.6 (79.1–84.0)
CI confidence interval
Table 2 Survival analysis of episodes of recurrent sickness absence
ICD-10 codes Time to onset in days
(99% CI) after index
episode
Median duration
in days (99% CI)
Total (%) sickness absence
days of all recurrences
Diseases of the musculoskeletal system M00–M99 409 (386–432) 36 (34–38) 424,697 (37%)
Mental & behavioral disorders F00–F99 328 (284–372) 62 (55–69) 246,162 (21%)
Diseases of the respiratory system J00–J99 396 (353–439) 11 (10–12) 79,889 (7%)
Injury & poisoning S00–T98 457 (375–539) 35 (30–40) 104,407 (9%)
Disease of the digestive system K00–K93 259 (148–370) 28 (20–36) 53,600 (5%)
Diseases of the nervous system & sensory organs G00–H95 303 (205–401) 21 (15–27) 54,159 (5%)
Diseases of the circulatory system I00–I99 343 (179–507) 65 (44–86) 70,666 (6%)
Diseases of the genitourinary system N00–N99 274 (187–361) 39 (21–57) 39,139 (4%)
Neoplasms C00–D48 205 (92–318) 215 (38–392) 34,884 (3%)
Infectious & parasitic diseases A00–B99 174 (18–380) 34 (0–99) 9,248 (1%)
Diseases of the skin & subcutaneous tissues D50–D89 291 (230–352) 18 (11–25) 15,015 (1%)
Endocrine & metabolic diseases E00–E90 406 (176–636) 40 (21–59) 12,946 (1%)
Disease of blood & blood forming organs L00–L99 373 (11–757) 50 (0–178) 4,377 (0%)
Total 384 (367–401) 35 (34–36) 1,148,187 (100%)
CI confidence interval
J Occup Rehabil (2010) 20:113–121 117
123
underestimation of the recurrence of musculoskeletal pain
when employees with complaints continued to work
instead of reporting sick.
Recurrences of sickness absence due to musculoskeletal
disorders were found to be associated with significant
additional suffering, high medical costs, and losses in
productivity, contributing disproportionately to the total
societal burden of musculoskeletal disease [33–35]. Our
results showed that the burden of recurrent sickness
absence, in terms of the number of working days lost due to
recurrent sickness absence, was highest in the category of
musculoskeletal disorders: 37% of days of recurrent sick-
ness absence were due to musculoskeletal disorders.
Recurrent episodes of sickness absence due to muscu-
loskeletal disorders were related to SES with employees
with a low SES being at higher risk than employees of high
SES. Health problems and sickness absence are known to
occur more frequently among employees with a low SES
than in employees of high position [36–40]. Recurrent
sickness absence due to mental disorders, however, was not
related to the socioeconomic status of employees. Appar-
ently, recurrent sickness absence due to mental disorders is
as common in employees with a high SES as in employees
of low SES.
The salary scales were associated with the recurrence of
sickness absence. Employees with a salary scale ranging
Table 3 Poisson regression analysis of recurrent sickness absence due to musculoskeletal and mental disorders adjusted for company
Musculoskeletal (Na = 10,678) Mental (Na = 6,211)
N RRb (99% CIc) N RRb (99% CIc)
Gender
Male 6,730 1 3,477 1
Female 3,948 0.98 (0.92–1.03) 2,734 1.00 (0.93–1.09)
Age
\35 years 2,023 1 1,340 1
35–44 years 3,492 0.97 (0.91–1.04) 2,232 0.92 (0.85–1.01)
45–54 years 3,794 1.00 (0.93–1.07) 2,048 0.91 (0.82–1.00)
C55 years 1,369 1.05 (0.96–1.14) 591 1.05 (0.92–1.20)
Marital status
Unmarried 3,769 1 2,601 1
Married 6,909 0.98 (0.94–1.03) 3,610 0.95 (0.89–1.01)
Socioeconomic status
Low 2,708 1 1,470 1
Lower average 2,659 0.95 (0.90–1.01) 1,573 1.00 (0.92–1.09)
Upper average 2,618 0.94 (0.89–0.99)** 1,560 1.02 (0.94–1.11)
High 2,693 0.93 (0.88–0.98)** 1,608 1.01 (0.93–1.09)
Employment
Full-time 5,518 1 3,556 1
Part-time 5,160 1.01 (0.95–1.07) 2,655 1.03 (0.94–1.12)
Duration of employment
\5 years 3,580 1 2,014 1
5–9 years 1,407 0.68 (0.63–0.72)** 758 0.72 (0.65–0.79)**
10–14 years 960 0.82 (0.75–0.89)** 773 0.81 (0.73–0.90)**
15–19 years 919 0.77 (0.70–0.84)** 679 0.81 (0.73–0.91)**
C20 years 3,812 0.83 (0.77–0.89)** 1,987 0.81 (0.74–0.89)**
Salary scale
1 and 2 3,578 1 1,133 1
3 3,980 0.96 (0.90–1.04) 1,289 0.92 (0.82–1.03)
4 and 5 1,302 0.87 (0.80–0.95)** 1,063 0.88 (0.78–0.99)*
6 and 7 1,221 0.79 (0.72–0.87)** 1,497 0.87 (0.78–0.98)**
C8 597 0.66 (0.58–0.75)** 1,229 0.82 (0.72–0.93)**
a Cases with missing values on independent variables are excluded
b RR rate ratio
c CI confidence interval with * P \ 0.01 and ** P \ 0.001
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from 1 to 3 were mostly unskilled postmen and post sorters,
or cable workers, whereas, those with a salary scale of 4
and higher were skilled post officers, administrators,
computer experts, and managers. Obviously, due to the
type of work they do, unskilled employees are at increased
risk of recurrent sickness absence due to musculoskeletal
disorders.
Besides the type of work, the duration of employment was
related to the recurrence of sickness absence. Employees
with a short record of service had a higher risk of recurrent
sickness absence due to musculoskeletal and mental disor-
ders. On the one hand, employees with a short duration of
employment may have difficulties in coping with the work
demands. On the other hand, employees who have worked
only a few years for a company are likely to be less com-
mitted to the company and may find it easier to report sick
when having complaints, compared to employees who have
worked for C5 years for a company.
Policy Implications
One policy implication of our findings is that the (cost-
)effectivity of return to work interventions among sick-
listed employees with musculoskeletal disorders or mental
disorders should not only be estimated according to the
duration of the sickness absence episode, but should also be
based on recurrent sickness absences after full return to
work with equal earnings, especially among unskilled
workers with a short record of service. Molde Hagen
noticed that, during a 3 year follow-up, there were fewer
days of sickness compensation in the intervention group
than in the control group [41]. However, this difference
was caused by a more rapid return to work during the first
year, while there was no significant difference in the sec-
ond or third year. By performing multi-state analysis, Lie
et al. [42] found a short-term effect of an intervention on
the transition of the state ‘sick-listed’ to the state ‘returned
to work’, but no long-term effects on the probability to
remain in the latter state. Our results showed that without
any intervention, 50% of recurrent episodes of sickness
absence due to musculoskeletal disorders occurred within
409 days after the index episode, and 50% of recurrent
episodes of sickness absence due to mental disorders within
328 days. Thus, the other 50% of recurrences do not occur
in the first year after the index episode. Future intervention
studies should not only focus on expediting return to work,
but also at sustaining employees at work [43].
Another policy implication of our findings is that, given
the considerable burden of recurrent sickness absence,
prevention of relapse should be part of any treatment
program or intervention aimed at return to work. This
implies that employees who have returned to work after a
long-term episode of sickness absence are monitored by
health care providers to determine whether they are able to
sustain the full work status. When complaints increase, or
work functioning decreases, employees may consult
health care providers who can teach them how to perform
activities of daily living, despite their impairments [44],
or support them when work adjustments are necessary.
Ergonomic worksite assessments, work adjustments, and
contacts between health care provider and the workplace
reduced the duration of disability and the associated costs
[45, 46]. Although these studies did not focus on recur-
rences of sickness absence, we assume that workplace-
based interventions can be important to sustain employees
in their work after a long-term episode of sickness absence.
It would be worthwhile to investigate the effects of such
interventions as a relapse prevention strategy. Future
inception cohort studies are necessary to identify constructs
of recurrent sickness absence needed for policy-making. If
the results of future clinical trials show that workplace-
based interventions also reduce recurrent sickness absence,
then they should be targeted at unskilled employees in low
occupational classes with a short record of service and low
socioeconomic positions, because our results indicate that
these employees have the highest risk of recurrent sickness
absence.
Strengths and Weaknesses of the Study
The strength of our study is that we could monitor a large
dynamic population of employees over a period of 7 years.
Furthermore, we used the OP diagnosis on the sickness
certificates. However, selecting episodes of sickness absence
that are medically certified by OPs implies a source of bias,
because sickness absence with a duration of 1–3 weeks is not
medically certified, and was not included in the study.
Sickness absence was analyzed according to the ICD-10
categories, because the validity of specific diagnoses within
the ICD-10 categories has been subject to much debate in
occupational health care [47]. The sickness absence register
only contained one ICD-10 code per episode, which is a
common shortcoming in studies of this type [48]. If an OP
changes a diagnosis during an episode of sickness absence,
for instance, from a physical disorder to mental disorder, the
entire episode is certified as mental disorder. This means that
we had no knowledge about co-morbidity. Furthermore, it
should be acknowledged that recurrent sickness absence can
have different causes, even within the same ICD category.
For instance, an employee who was absent from work
because of low back pain can have a recurrent episode of
sickness absence due to shoulder pain.
Diagnosis-specific recurrences can have been overesti-
mated if OPs are more inclined to certify symptoms and
signs in line with earlier diagnoses [48]. The recurrence
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rates may also be biased by return to work. Employees with
a serious disease are less likely to return to work, which
might explain, for instance, the lower recurrence rates of
neoplasms. The risk of recurrence may also have been
underestimated because of the high turnover in the study
population, since employees who have been absent due to
sickness are more likely to resign or to be discharged than
employees who have never reported sick [49]. Moreover,
the recurrence of sickness absence may depend on social
compensation systems. For example, in the Dutch sickness
absence insurance system, sickness absences with an
interval of less than 28 calendar days, are considered as one
episode. However, various different definitions of recurrent
episodes have been proposed in research on sickness
absence [31, 32]. Therefore, we assume that there are
societal differences in the risk of recurrent sickness
absence, and recommend that similar research should be
carried out in other countries.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
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